The EU cluster project canSERV is inviting anyone involved in a Molecular Tumour Board (MTB) – e.g., physicians, scientists, patient representatives, ethicists – to join the European Network for Personalised Oncology (ENPO) and its European Molecular Tumour Board Network (EMTBN).
The European Network for Personalised Oncology (ENPO) aims to provide state-of-the-art guidance and support to accelerate the implementation of personalised oncology.
Through canSERV, the ENPO will establish the European Molecular Tumor Board Network (EMTBN), which aims to guide the establishment of MTB Standard Operating Procedures (consensus standards) and the set-up of a public registry of MTB recommendation outcomes.
The ENPO and EMTBN will not be limited to the canSERV consortium partners but open to the wider community to be as inclusive and engaging as possible. Although participation in the networks is on a voluntary basis, some specific activities can be considered for cost reimbursement for those who will actively contribute.
The framework for these activities is created by the overarching canSERV project, in alignment with the EU Cancer Mission. The 19 canSERV partners offer a comprehensive portfolio of interdisciplinary and customised oncology services across the entire cancer research continuum.
Over the next three years, canSERV will offer more than 200 different unique, relevant, and valuable cutting-edge services for Personalised Oncology for the public and private (e.g., start-ups) community of cancer researchers, all accessible via a common platform and provided by complementary Research Infrastructures (RIs) in a synergistic, transnational way.
As such, canSERV capitalises on the critical mass of experts and cutting-edge services offered by the participating RIs and their extended networks, far extending the 19 partners to around one hundred.
You can find more information about canSERV’s partners and the project.
We sincerely hope that you will be able to accept our invitation with enthusiasm and kindly ask you to register here at your earliest convenience but preferably before March 27th, 2023.
Yours sincerely,
Prof. Enzo Medico
Leader of canSERV ENPO & EMTBN initiatives (canSERV WP6)
Coordinator of the EurOPDX RI, University of Torino.
Prof. Jens K. Habermann
Coordinator of canSERV
Director General, BBMRI-ERIC